Correlation Between Histogen and Acasti Pharma
Can any of the company-specific risk be diversified away by investing in both Histogen and Acasti Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Histogen and Acasti Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Histogen and Acasti Pharma, you can compare the effects of market volatilities on Histogen and Acasti Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Histogen with a short position of Acasti Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Histogen and Acasti Pharma.
Diversification Opportunities for Histogen and Acasti Pharma
-0.87 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Histogen and Acasti is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding Histogen and Acasti Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acasti Pharma and Histogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Histogen are associated (or correlated) with Acasti Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acasti Pharma has no effect on the direction of Histogen i.e., Histogen and Acasti Pharma go up and down completely randomly.
Pair Corralation between Histogen and Acasti Pharma
Given the investment horizon of 90 days Histogen is expected to generate 2.68 times more return on investment than Acasti Pharma. However, Histogen is 2.68 times more volatile than Acasti Pharma. It trades about 0.02 of its potential returns per unit of risk. Acasti Pharma is currently generating about 0.03 per unit of risk. If you would invest 85.00 in Histogen on September 23, 2024 and sell it today you would lose (82.23) from holding Histogen or give up 96.74% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 92.15% |
Values | Daily Returns |
Histogen vs. Acasti Pharma
Performance |
Timeline |
Histogen |
Acasti Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
Histogen and Acasti Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Histogen and Acasti Pharma
The main advantage of trading using opposite Histogen and Acasti Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Histogen position performs unexpectedly, Acasti Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will offset losses from the drop in Acasti Pharma's long position.Histogen vs. Virax Biolabs Group | Histogen vs. Altamira Therapeutics | Histogen vs. Aileron Therapeutics | Histogen vs. Artelo Biosciences |
Acasti Pharma vs. Tonix Pharmaceuticals Holding | Acasti Pharma vs. Jaguar Animal Health | Acasti Pharma vs. Ibio Inc | Acasti Pharma vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bonds Directory Find actively traded corporate debentures issued by US companies |